UNSPSC 51141567: Milacemide

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51141567

Definition

This classification denotes an anticonvulsant agent with the molecular formula C7H16N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0HXT24RECU, chemically known as acetamide, 2-(pentylamino)- but generally known as milacemide, which bears US NIH Compound Identifier 53569. European Medicines Agency schedules Milacemide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08960MIG.

Read the full definition

The term MILACEMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). MILACEMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule milacemide under HS 29241900 and SITC 51471. As of Q4 2014, MILACEMIDE remains the US FDA Preferred Term for this commodity. Milacemide bears US NLM identifiers UMLS ID C0066545 and NCI Concept Code C81467. SMILES: O=C(N)CNCCCCC.

About UNSPSC 51141567

UNSPSC 51141567 Milacemide is a Commodity code that maps nominally to a pharmaceutical ingredient, but the recent state and local procurement activity under this code does not reflect pharmaceutical manufacturing or bulk chemical supply. Seminole County, Florida's June 2026 IFB for naloxone and drug deactivation systems—a public health and emergency response procurement—appears to be the only recent state or local opportunity tagged to this code, and it involves finished medical devices and harm-reduction products rather than milacemide specifically. The mismatch between the code's pharmaceutical-ingredient scope and the actual work being solicited suggests either a data-entry error in the county's coding or a divergence between the UNSPSC taxonomy and how a specific issuing body has applied it. State and local procurement activity under this code shows little relevant recent volume.

Seminole County in Florida is the sole identified recent issuer. The IFB 60459723LAS, posted June 30, 2026, seeks annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Bids were due July 26, 2023 (note: the posted date and due date are inconsistent in the source), with responses submitted electronically through the county's e-Procurement Portal. The contract carried a two-year initial term with one-year renewal option, fixed-fee pricing, and compliance requirements including drug-free workplace certification, E-Verify authorization, and specific insurance coverages. FEMA funding was noted as a potential source, introducing federal compliance obligations. Vendors were responsible for all shipping and delivery costs. Business development professionals should verify the actual UNSPSC coding when considering opportunities tagged to this code, as the recent activity does not align with the stated commodity.

Quick answers

What is UNSPSC 51141567?

UNSPSC 51141567 is Milacemide, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51141567?

UNSPSC 51141567 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51141567

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code